Log in
NYSEAMERICAN:MLSS

Milestone Scientific Stock Forecast, Price & News

$1.37
-0.13 (-8.67 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.37
Now: $1.37
$1.58
50-Day Range N/A
52-Week Range
$0.72
Now: $1.37
$3.05
Volume522,444 shs
Average Volume441,420 shs
Market Capitalization$90.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.15 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MLSS
CUSIPN/A
Phone+1-973-5352717

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Market Cap$90.24 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
$1.37
-0.13 (-8.67 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Milestone Scientific?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Milestone Scientific
.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Milestone Scientific
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) issued its quarterly earnings data on Friday, August, 14th. The medical instruments supplier reported ($0.06) EPS for the quarter. The medical instruments supplier had revenue of $0.17 million for the quarter.
View Milestone Scientific's earnings history
.

What price target have analysts set for MLSS?

2 analysts have issued 12 month target prices for Milestone Scientific's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Milestone Scientific's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 192.0% from the stock's current price.
View analysts' price targets for Milestone Scientific
.

Are investors shorting Milestone Scientific?

Milestone Scientific saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 2,460,000 shares, an increase of 20.6% from the July 30th total of 2,040,000 shares. Based on an average daily volume of 558,000 shares, the short-interest ratio is currently 4.4 days.
View Milestone Scientific's Short Interest
.

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT), Cellectar Biosciences (CLRB), Plug Power (PLUG), Acasti Pharma (ACST), Eldorado Gold (EGO), Matinas BioPharma (MTNB), Alimera Sciences (ALIM), Advanced Micro Devices (AMD), Amarin (AMRN) and Cyclacel Pharmaceuticals (CYCC).

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the following people:
  • Mr. Leonard A. Osser, Founder, Interim CEO & Director (Age 72)
  • Mr. Joseph D'Agostino CPA, CPA, CFO & COO (Age 67)
  • Ms. Sharon Smith, Exec. VP of Global Sales & Marketing
  • Mr. Gian Domenico Trombetta, Pres & CEO of Wand Dental Inc. and Director (Age 58)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

Who are Milestone Scientific's major shareholders?

Milestone Scientific's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bridgeway Capital Management Inc. (0.36%), Nuveen Asset Management LLC (0.26%), Charles Schwab Investment Management Inc. (0.15%), Bank of New York Mellon Corp (0.13%), Jane Street Group LLC (0.11%) and New York State Common Retirement Fund (0.07%). Company insiders that own Milestone Scientific stock include Edward J Zelnick and Leonard Osser.
View institutional ownership trends for Milestone Scientific
.

Which major investors are selling Milestone Scientific stock?

MLSS stock was sold by a variety of institutional investors in the last quarter, including Commonwealth Equity Services LLC, and QCI Asset Management Inc. NY.
View insider buying and selling activity for Milestone Scientific
.

Which major investors are buying Milestone Scientific stock?

MLSS stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Bridgeway Capital Management Inc., Charles Schwab Investment Management Inc., Bank of New York Mellon Corp, Jane Street Group LLC, New York State Common Retirement Fund, American International Group Inc., and Goldman Sachs Group Inc.. Company insiders that have bought Milestone Scientific stock in the last two years include Edward J Zelnick, and Leonard Osser.
View insider buying and selling activity for Milestone Scientific
.

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $1.37.

How big of a company is Milestone Scientific?

Milestone Scientific has a market capitalization of $90.24 million. Milestone Scientific employs 16 workers across the globe.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is www.milesci.com.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at +1-973-5352717.

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.